| Term ID: |
410067 |
| Name: |
Increased level of L-fucose in urine |
| Synonym: |
|
| Definition: |
An increase in the level of L-fucose in the urine. |
| Comments: |
|
| Reference: |
HP:0410067 |
| Genes and Diseases: | |
Child Nodes: |
Sister Nodes: |
.. Abnormal circulating glycerol level (HP:0031795) 
|
..Abnormal circulating polysaccharide concentration (HP:0011012)
|
..Abnormal glucose homeostasis (HP:0011014)
|
..Abnormal glucose-6-phosphate dehydrogenase level (HP:0410176)
|
..Abnormal glycosylation (HP:0012345)
|
..Abnormality of glycolysis (HP:0004366)
|
..Abnormality of glycoside metabolism (HP:0003649)
|
..Decreased CSF erythritol concentration (HP:0410056)
|
..Decreased level of 1,5 anhydroglucitol in serum (HP:0410050)
|
..Decreased level of D-mannose in urine (HP:0410060)
|
..Decreased level of erythritol in urine (HP:0410055)
|
..Elevated circulating ribitol concentration (HP:0025550)
|
..Glycopeptiduria (HP:0012067)
|
..Glyoxalase deficiency (HP:0003258)
|
..Impairment of fructose metabolism (HP:0011033)
|
..Impairment of galactose metabolism (HP:0004915)
|
..Increased level of D-threitol in CSF (HP:0410058)
|
..Increased level of D-threitol in plasma (HP:0410057)
|
..Increased level of D-threitol in urine (HP:0410059)
|
..Increased level of galactitol in plasma (HP:0410061)
|
..Increased level of galactitol in red blood cells (HP:0410064)
|
..Increased level of galactitol in urine (HP:0410062)
|
..Increased level of N-acetylneuraminic acid in fibroblasts (HP:0410157)
|
..Increased level of N-acetylneuraminic acid in urine (HP:0410156)
|
..Increased level of ribitol in CSF (HP:0410071)
|
..Increased level of ribitol in urine (HP:0410070)
|
..Increased level of ribose in CSF (HP:0410073)
|
..Increased level of ribose in urine (HP:0410072)
|
..Increased level of xylitol in CSF (HP:0410075)
|
..Increased level of xylitol in urine (HP:0410074)
|
..Increased urinary sedoheptulose (HP:0025157)
|
..Oligosacchariduria (HP:0010471)
|
| Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
|---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | APC CL E G H | 324 | 583 | OMIM:613659 | Gastric cancer, somatic | | | | 3179 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | CASP10 CL E G H | 843 | 1500 | OMIM:613659 | Gastric cancer, somatic | | | | 87 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | ERBB2 CL E G H | 2064 | 3430 | OMIM:613659 | Gastric cancer, somatic | | | | 77 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:613659 | Gastric cancer, somatic | | | | 175 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | IL1B CL E G H | 3553 | 5992 | OMIM:613659 | Gastric cancer, somatic | | | | 2 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | IL1RN CL E G H | 3557 | 6000 | OMIM:613659 | Gastric cancer, somatic | | | | 40 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | IRF1 CL E G H | 3659 | 6116 | OMIM:613659 | Gastric cancer, somatic | | | | 2 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | KLF6 CL E G H | 1316 | 2235 | OMIM:613659 | Gastric cancer, somatic | | | | 18 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | KRAS CL E G H | 3845 | 6407 | OMIM:613659 | Gastric cancer, somatic | | | | 196 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | KRAS CL E G H | 3845 | 6407 | OMIM:260350 | Pancreatic cancer | | | | 196 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | KRT18 CL E G H | 3875 | 6430 | OMIM:215600 | Cirrhosis, familial | | | | 19 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | MUTYH CL E G H | 4595 | 7527 | OMIM:613659 | Gastric cancer, somatic | | | | 592 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:613659 | Gastric cancer, somatic | | | | 162 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | SMAD4 CL E G H | 4089 | 6770 | OMIM:260350 | Pancreatic cancer | | | | 504 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | STK11 CL E G H | 6794 | 11389 | OMIM:260350 | Pancreatic cancer | | | | 740 | | | | HP:0410067 | HP:0410067 | Increased level of L-fucose in urine | 0 | TP53 CL E G H | 7157 | 11998 | OMIM:260350 | Pancreatic cancer | | | | 911 | | |
Genes (15) :APC CASP10 ERBB2 FGFR2 IL1B IL1RN IRF1 KLF6 KRAS KRT18 MUTYH PIK3CA SMAD4 STK11 TP53
Diseases (3) :OMIM:613659 OMIM:260350 OMIM:215600 |
Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.
|
